Latest In Depth
The COVID-19 pandemic doesn't end with a viable vaccine but with a vaccinated population
Added: 19 Nov 2020
With a potential finishing line suddenly appearing over the horizon, getting competitors to the end…
Reviewing EU microbiological safety cabinet regulations
Added: 18 Nov 2020
Following up on the lab management article 'Microbiological safety cabinets - On-site and maintenan…
Embracing change to keep pace with routine test demand
Added: 23 Oct 2020
Penny Pinnock looks at why NHS trusts must work together to meet the challenges facing their labora…
Selecting the right sterile cleanroom clothing solution for compliance with EU GMP Annex I
Added: 23 Oct 2020
Sponsored Content
The new EU GMP Annex I guidelines will require sterile product manufacturers to …
Solving process safety and scale up
Added: 2 Oct 2020
In industries ranging from pharmaceuticals to fine chemicals, there is a need to take small, labora…
Improving the luck of the horseshoe crab
Added: 21 Sep 2020
Following some recent media controversy, Allen Burgenson, and Glenn Gauvry update our original July…
Big data for understanding small molecules; a case study
Added: 25 Aug 2020
As big data continues to transform the industry must we remain so reluctant to share data? In her a…
Collaborate to accumulate
Added: 25 Aug 2020
Pharmaceutical research and development has historically been shrouded in mystery; a secretive acti…
The great vaccine paradox
Added: 3 Aug 2020
by Dermot Martin
What happens if the best defence against a virus develops an image problem? As we…
GSK partners CRISPR discoverer to develop rapid COVID-19 test
Added: 5 Jun 2020
Gene editor turns gene detective: Dermot Martin investigates a successful COVID-19 test development…
Re-purposing familiar drugs to defend against COVID 19
Sarah Lawton | Added: 15 May 2020
By Dermot Martin
Drugs with a successful track record against rare diseases occasionally show posi…
What’s your poison?
Sarah Lawton | Added: 11 May 2020
Why are so many drugs derived from natural sources on the market to treat human disease? Venom-mast…
Going (anti)viral
Added: 28 Apr 2020
Dermot Martin catches us up with the rapid reaction of the biopharma community to meet the Covid-19…
Going round in circles
Added: 9 Apr 2020
Single use plastics are a staple in the lab – but they are also are part of the plastics pollution …
Coronavirus – is it just “a type of ‘flu”?
Added: 2 Apr 2020
The virology, genomics, epidemiology and medical response – Chief Virology Examiner at the Institut…
Shining a light on diabetes
Added: 17 Mar 2020
The complexity of glycogen storage diseases like diabetes means a reductionist approach just won’t …
Does gene therapy put safety second?
Added: 15 Mar 2020
The delivery of gene therapies relies almost entirely on viral vectors. So, when it comes to the pr…
A certain ratio
Added: 27 Jan 2020
Has CRISPR just given us the ability to change the sex ratio in mammals? Dermot Martin reports on n…
Can we afford to cure the incurable?
Added: 14 Jan 2020
Putting us on the very cusp of a medical revolution – gene therapy could cure the incurable. But as…
Moving from push to pull
Added: 9 Dec 2019
Nothing less than an entirely new model of drug development is needed if we are to create new antib…
